Skip to main content
. 2021 Feb;11(1):50–55. doi: 10.21037/cdt-20-830

Table 1. Comparison of the general characteristics and results of laboratory test among the three groups.

Variables SR pAF PAF χ2/F value P value
Cases 84 76 73
Male [cases (%)] 41 (48.8) 34 (44.7) 33 (45.2) 0.376 0.829
Age (years) 62±7 64±7 67±9ab 7.383 0.001
ACEI [cases (%)] 68 (81.0) 52 (68.4) 58 (79.5) 4.008 0.135
Hypertension [cases (%)] 59 (70.2) 46 (60.5) 54 (74.0) 3.334 0.189
SBP (mmHg) 127±7 127±7 127±7 0.008 0.992
DBP (mmHg) 70±7 72±7 69±7 2.272 0.105
BMI (kg/m2) 21.0±1.4 21.3±1.2 21.0±1.4 0.332 0.718
HGB (g/L) 128±16 125±21 124±25 0.600 0.550
WBC (10^9/L) 6.54±1.49 6.31±1.52 6.52±1.48 0.625 0.536
AST (U/L) 28±29 27±29 27±29 0.040 0.961
Cr (umol/L) 85±20 88±20 85±20 0.596 0.552
TG (mmol/L) 1.42±1.06 2.01±1.70a 1.33±0.97b 6.182 0.002
LDL-C (mmol/L) 2.34±0.72 2.67±0.87a 2.33±0.75b 4.731 0.01
GLU (mmol/L) 5.4±0.6 5.5±0.6 5.3±0.6 1.131 0.325
hsCRP (mg/L) 2.5±0.7 5.9±7.5a 6.3±3.7a 15.435 <0.001
AngII (pg/mL) 158.9±66.2 188.8±58.6a 249.6±66.9ab 40.083 <0.001
Renin (pg/mL) 26.0±27.6 55.3±27.9a 85.9±38.9ab 70.059 <0.001
Ald (pg/mL) 177.2±64.5 210.2±29.2a 347.6±94.2ab 114.751 <0.001
UA (umol/L) 301.7±77.7 408.0±105.3a 447.3±114.3ab 45.718 <0.001
LVEF (%) 57.5±7.2 55.6±4.3a 53.8±6.1a 7.486 0.001
LVEDD (mm) 49.2±3.2 50.2±3.7 51.8±5.5ab 7.193 0.001
LAD (mm) 36.2±2.2 37.0±2.3 38.1±3.1ab 11.24 <0.001

Comparison with SR group: a, P<0.05; compared with pAF group: b, P<0.05. 1 mmHg =0.133 kPa; ACEI, angiotensin converting enzyme inhibitor; SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; HGB, hemoglobin; WBC, white blood cell; AST, aspartate aminotransferase; Cr, Creatinine; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; GLU, fasting blood glucose; hsCRP, high sensitivity C-reactive protein; AngII, angiotensin II; Ald, aldosterone; UA, uric acid; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end-diastolic diameter; LAD, left atrium diameter.